On October 8, 2026 Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning ("ML") platform with multiple clinical stage drug programs, reported that Lantern management will be presenting at the ThinkEquity Conference on Thursday, October 15, 2026, at 3:30 p.m. ET at the Mandarin Oriental in New York, NY.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Webcast Link: https://event.summitcast.com/view/GXv6JAoMEphytK6ggozCk7/VS4pGMrvkgq2xwHrNQevWX
Conference Registration Link: View Source

Lantern Pharma management will be available for one-on-one meetings held throughout the conference.

(Press release, Lantern Pharma, OCT 8, 2026, View Source [SID1234673286])